{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2014"],"condition":["Neoplasm Metastasis","Colorectal Neoplasms","Colon Cancer Liver Metastasis","Liver Neoplasms","Colonic Neoplasms","Neoplasms","Malignant Neoplasm of Large Intestine"],"disease":["Neoplasm Metastasis","Malignant Neoplasm Of Large Intestine","Colorectal Neoplasms","Colon Cancer Liver Metastasis","Liver Neoplasms","Colonic Neoplasms","Neoplasms"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2183806"],"location":["France"],"study_start_month":["7"],"keyword":["TNM Staging Primary Tumor (T)","Unresectable","Colectomy","Unresectable synchronous liver metastasis","Asymptomatic primary colon cancer","Primary tumor resection"],"repository":["ECRIN MDR"],"study_status":["Not provided"],"additional_accession":[]},"is_claimable":false,"name":"Colectomy in Patients With Asymptomatic and Unresectable Stage IV Colon Cancer","description":"The present study is a multicentric randomized phase III trial designed to assess whether overall survival and quality of life are improved in patients with asymptomatic colon cancer and unresectable SLM treated with resection of the PT followed by chemotherapy versus chemotherapy alone.","dates":{"creation":"2014-07-15"},"accession":"2183806","cross_references":{"ClinicalTrials___gov":["NCT02363049"]}}